Short- and mid-term intravascular ultrasound analysis of the new ENDEAVOR CR zotarolimus-eluting stent: Insights from the RESOLUTE trial

被引：0
|
作者：
Waseda, Katsuhisa [1 ]
Yamasaki, Masao [1 ]
Koizumi, Tomomi [1 ]
Ako, Junya [1 ]
Honda, Yasuhiro [1 ]
Meredith, Ian [2 ]
Worthley, Stephen [3 ]
Whitbourn, Robert J. [4 ]
Walters, Darren [5 ]
Fitzgerald, Peter J. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Monash Med Ctr, Clayton, Vic 3168, Australia
[3] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[4] St Vincents Hosp, Melbourne, Vic, Australia
[5] Prince Charles Hosp, Brisbane, Qld 4032, Australia
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 100卷 / 8A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：19L / 20L
页数：2
相关论文
共 50 条
  • [41] Coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13 months: an optical coherence tomography substudy from the RESOLUTE AC trial
    Gutierrez-Chico, J. L.
    Van Geuns, R. J.
    Regar, E.
    Kelbaek, H.
    Escaned-Barbosa, J.
    Di Mario, C.
    Garcia-Garcia, H. M.
    Silber, S.
    Windecker, S.
    Serruys, P. W.
    EUROPEAN HEART JOURNAL, 2011, 32 : 405 - 406
  • [42] Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial
    Diletti, Roberto
    Garcia-Garcia, Hector M.
    Bourantas, Christos V.
    van Geuns, Robert Jan
    Van Mieghem, Nicolas M.
    Vranckx, Pascal
    Zhang, Yao-Jun
    Farooq, Vasim
    Iqbal, Javaid
    Wykrzykowska, Joanna J.
    de Vries, Ton
    Swart, Michael
    Teunissen, Yvonne
    Negoita, Manuela
    van Leeuwen, Frank
    Silber, Sigmund
    Windecker, Stephan
    Serruys, Patrick W.
    HEART, 2013, 99 (17) : 1267 - 1274
  • [43] Randomized, double-blind, Multicenter study of the endeavor Zotarolimus-Eluting phosphorylcholine-encapsulated Stent for treatment of native coronary artery lesions - Long-term efficacy and safety of the ENDEAVOR II trial
    Konorza, T. F. M.
    HERZ, 2007, 32 (05) : 428 - 428
  • [44] Long-Term Outcomes of Zotarolimus-Eluting with Sirolimus-Eluting and Paclitaxel-Eluting Stent in Diabetic Patients: 2-Year Analysis of the ZEST Randomized Trial
    Park, Dukwoo
    Kim, Yoo Ri
    Sun, Byung Joo
    Cho, Sung Won
    Kim, Won-Jang
    Lee, Jong-Young
    Kang, Soo-Jin
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    CIRCULATION, 2010, 122 (21)
  • [45] Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial
    Tandjung, Kenneth
    Basalus, Mounir W. Z.
    Sen, Hanim
    Stoel, Martin G.
    van Houwelingen, K. Gert
    Louwerenburg, J. W.
    de Man, Frits H. A. F.
    Linssen, Gerard C. M.
    Said, Salah A. M.
    Kleijne, Miep A. W. J.
    van der Palen, Job
    von Birgelen, Clemens
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (03) : 396 - 405
  • [46] Long-Term Efficacy and Safety of Zotarolimus-Eluting Stent in Patients With Diabetes Mellitus: Pooled 5-year Results From the ENDEAVOR III and IV Trials
    Vardi, Moshe
    Burke, David A.
    Bangalore, Sripal
    Pencina, Michael J.
    Mauri, Laura
    Kandzari, David E.
    Leon, Martin B.
    Cutlip, Donald E.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2013, 82 (07) : 1031 - 1038
  • [47] Clinical Outcomes Following Resolute Zotarolimus-eluting Stent Implantation in Diabetic versus Non-Diabetic Patients Suitable for Percutaneous Coronary Revascularization: Insights From a Multicenter Italian Registry
    Ielasi, Alfonso
    Latib, Azeem
    Burzotta, Francesco
    Summaria, Francesco
    De Vita, Maria
    Anzuini, Angelo
    Larosa, Claudio
    Della Rovere, Francesco
    Lanzone, Saverio
    Manzoli, Alessandro
    Giovannelli, Francesca
    Colombo, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B67 - B68
  • [48] Clinical Outcome of Patients With and Without Diabetes Mellitus After Percutaneous Coronary Intervention With the Resolute Zotarolimus-Eluting Stent 2-Year Results From the Prospectively Pooled Analysis of the International Global RESOLUTE Program
    Silber, Sigmund
    Serruys, Patrick W.
    Leon, Martin B.
    Meredith, Ian T.
    Windecker, Stephan
    Neumann, Franz-Josef
    Belardi, Jorge
    Widimsky, Petr
    Massaro, Joe
    Novack, Victor
    Yeung, Alan C.
    Saito, Shigeru
    Mauri, Laura
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (04) : 357 - 368
  • [49] Intravascular Ultrasound Results From the ENDEAVOR IV Trial Randomized Comparison Between Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
    Waseda, Katsuhisa
    Miyazawa, Akiyoshi
    Ako, Junya
    Hasegawa, Takao
    Tsujino, Ichizo
    Sakurai, Ryota
    Yock, Paul G.
    Honda, Yasuhiro
    Kandzari, David E.
    Leon, Martin B.
    Fitzgerald, Peter J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (08) : 779 - 784
  • [50] A New Strategy for Discontinuation of Dual Antiplatelet Therapy The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
    Kim, Byeong-Keuk
    Hong, Myeong-Ki
    Shin, Dong-Ho
    Nam, Chung-Mo
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Kang, Tae-Soo
    Park, Byoung-Eun
    Kang, Woong-Chol
    Lee, Seung-Hwan
    Yoon, Jung-Han
    Hong, Bum-Kee
    Kwon, Hyuck-Moon
    Jang, Yangsoo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (15) : 1340 - 1348
12345